Peptidus Biotech is an AI-driven, deep tech company specializing in the discovery and design of peptide-based therapies for animal health. Based in Brazil, it uses its proprietary LAIKA platform to develop innovative, scalable treatments.
Peptidus Biotech is a Brazil-based deep tech company that utilizes its proprietary, multi-layered artificial intelligence platform, LAIKA, to accelerate the discovery and design of novel peptide-based therapies for animal health. By integrating bio-inspired design with computational approaches, the company identifies and refines amino acid sequences to produce stable, effective peptide candidates. This technology enables a drug discovery process that aims to be faster and more cost-efficient than traditional methods while addressing critical health challenges in livestock and companion animals. The company operates under a licensing business model, partnering with global and regional industry leaders to bring its innovations to market.
The company's focus is on delivering high-impact solutions for unmet needs, such as developing antibiotic-free treatments for conditions like bovine mastitis, as well as addressing dermatological healing, obesity, and infectious diseases. Their research is supported by a team of scientists and developers and has been recognized with multiple awards in the deep tech and health innovation sectors. Peptidus Biotech is based at the Biotic Technological Park in Brasília and actively engages with international biotech communities, including presentations at major industry conventions and conferences, to connect its research with global markets.